X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (27) 27
internal medicine (23) 23
cardiology and cardiovascular medicine (22) 22
humans (21) 21
cardiology (20) 20
heart attacks (18) 18
task forces (18) 18
cardiac & cardiovascular systems (17) 17
cardiovascular disease (17) 17
index medicus (15) 15
writing (14) 14
abridged index medicus (13) 13
heart (11) 11
percutaneous coronary intervention (11) 11
practice guidelines (11) 11
care and treatment (10) 10
united states (10) 10
american heart association (9) 9
coronary artery disease (9) 9
focused update (9) 9
risk factors (9) 9
accf/aha practice guidelines (8) 8
cardiology - standards (8) 8
hospitals (8) 8
risk assessment (8) 8
adults (7) 7
cholesterol (7) 7
coronary vessels (7) 7
diabetes (7) 7
heart failure (7) 7
patients (7) 7
pharmaceutical industry (7) 7
acc/aha practice guideline (6) 6
blood pressure (6) 6
cardiovascular diseases (6) 6
clinical medicine (6) 6
drug therapy (6) 6
medical imaging (6) 6
acc/aha clinical practice guideline (5) 5
cardiac patients (5) 5
colleges & universities (5) 5
coronary heart disease (5) 5
diagnosis (5) 5
disease prevention (5) 5
myocardial infarction (5) 5
patient compliance (5) 5
quality (5) 5
risk reduction behavior (5) 5
societies, medical (5) 5
transluminal angioplasty (5) 5
acute coronary syndrome (4) 4
adult (4) 4
angina pectoris (4) 4
anticoagulants (4) 4
aspirin (4) 4
association task-force (4) 4
cardiology - methods (4) 4
cardiovascular diseases - prevention & control (4) 4
college-of-cardiology (4) 4
computed tomographic angiography (4) 4
coronary stents (4) 4
coronary-artery-disease (4) 4
disease management (4) 4
dual antiplatelet therapy (4) 4
elevation myocardial-infarction (4) 4
heart attack (4) 4
hypertension (4) 4
intubation (4) 4
medical societies (4) 4
prevention (4) 4
primary prevention (4) 4
stable ischemic heart disease (4) 4
stroke (4) 4
surgery (4) 4
acc/aha clinical practice guidelines (3) 3
acc/aha/scai/ama-pcpi/ncqa performance measures (3) 3
accf appropriate use criteria (3) 3
advisory committees - standards (3) 3
ambulatory-level quality (3) 3
antiplatelet therapy (3) 3
arrhythmias, cardiac - therapy (3) 3
biomarkers (3) 3
cardiothoracic surgery (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
committees (3) 3
computed tomography (3) 3
converting-enzyme-inhibitors (3) 3
coronary artery bypass graft surgery (3) 3
coronary calcium score (3) 3
councils (3) 3
decision making (3) 3
drug-eluting stents (3) 3
electrocardiogram (3) 3
electrocardiography (3) 3
estimated metabolic equivalents of exercise (3) 3
exercise (3) 3
glycoprotein iib/iiia receptor antagonists (3) 3
guidelines (3) 3
health policy and outcome research (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 12/2009, Volume 54, Issue 23, pp. 2205 - 2241
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2018, Volume 71, Issue 19, pp. 2199 - 2269
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3168 - 3209
...). [...]raising the threshold for LDL-C on maximal statin therapy to initiate a PCSK9 inhibitor should improve its cost-effectiveness (Figure 3... 
ACC/AHA Clinical Practice Guidelines | cardiovascular disease | patient compliance | risk assessment | lipids | drug therapy | risk reduction discussion | secondary prevention | hydroxymethylglutaryl-CoA reductase inhibitors/statins | biomarkers | proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors | diabetes mellitus | hypercholesterolemia | pharmacological | Guidelines | LDL-cholesterol | coronary artery calcium score | ezetimibe | primary prevention | cholesterol | risk treatment discussion | Risk Assessment - methods | Hypercholesterolemia - blood | Risk Reduction Behavior | United States | Cardiovascular Diseases - prevention & control | Humans | Ezetimibe - pharmacology | Biomarkers - blood | Cardiology - standards | Medication Therapy Management - standards | American Heart Association | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Proprotein Convertase 9 - antagonists & inhibitors | Hypercholesterolemia - diagnosis | Cardiovascular Diseases - psychology | Hypercholesterolemia - therapy | Anticholesteremic Agents - pharmacology | Cardiology - methods | Hypercholesterolemia - epidemiology | Calcification (ectopic) | Lipoproteins (low density) | Therapy | Calcium | Hispanic Americans | Clinical trials | Cardiovascular disease | Metabolic syndrome | Inflammatory diseases | Risk factors | Body mass index | Proliferating cell nuclear antigen | Health behavior | Drug dosages | Statins | Age | Task forces | Decision making | Coronary artery | Whites | Risk analysis | Patients | Patient compliance | Cholesterol | Disease prevention | Ethnicity | Inhibitors | Arteriosclerosis | Lifestyles | Diabetes
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, p. e285
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2006, Volume 48, Issue 5, pp. e247 - e346
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 02/2014, Volume 63, Issue 7, pp. 722 - 745
Journal Article
Journal Article
Journal Article
Europace (London, England), ISSN 1532-2092, 2006, Volume 8, Issue 9, pp. 746 - 837
Journal Article